Nicolas Wentzensen Selected Research

Atypical Squamous Cells of the Cervix

1/2022	Different human papillomavirus types share early natural history transitions in immunocompetent women.
1/2019	Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology.
12/2016	Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines.
12/2015	p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women.
10/2015	The Value of Endocervical Curettage in Addition to Biopsies in Women Referred to Colposcopy.
10/2012	p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and meta-analysis.
1/2011	Risk of cervical intraepithelial neoplasia 2+ among women with a history of previous treatment for cervical intraepithelial neoplasia: ASCUS and LSIL Pap smears after treatment.
5/2009	A study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance-low-grade squamous intraepithelial lesion triage study.
2/2007	Triage of women with ASCUS and LSIL cytology: use of qualitative assessment of p16INK4a positive cells to identify patients with high-grade cervical intraepithelial neoplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicolas Wentzensen Research Topics

Disease

105	Neoplasms (Cancer) 10/2022 - 05/2004
49	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 03/2011
39	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 01/2002
24	Endometrial Neoplasms (Endometrial Cancer) 04/2021 - 06/2012
22	Carcinogenesis 12/2021 - 10/2006
16	Uterine Cervical Dysplasia 01/2023 - 12/2005
16	Ovarian Epithelial Carcinoma 01/2021 - 06/2011
12	Inflammation (Inflammations) 01/2022 - 05/2013
12	Infections 01/2020 - 10/2008
11	Papillomavirus Infections 01/2017 - 10/2010
9	Atypical Squamous Cells of the Cervix 01/2022 - 02/2007
9	Obesity 01/2021 - 06/2011
7	Anus Neoplasms (Anal Cancer) 12/2022 - 11/2012
7	Endometriosis 01/2022 - 05/2013
7	Carcinoma (Carcinomatosis) 01/2020 - 05/2004
6	Breast Neoplasms (Breast Cancer) 06/2019 - 06/2013
5	Endometrioid Carcinoma 10/2019 - 01/2008
4	Squamous Intraepithelial Lesions 01/2019 - 05/2009
3	Uterine Neoplasms (Uterine Cancer) 01/2022 - 01/2021
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 05/2004
2	Ovarian Cysts (Ovarian Cyst) 01/2022 - 01/2014
2	COVID-19 10/2021 - 07/2021
2	Uterine Hemorrhage (Uterine Bleeding) 10/2021 - 01/2021
2	Hyperplasia 10/2021 - 01/2020
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 06/2010
2	Insulin Resistance 07/2015 - 12/2014
2	Microsatellite Instability 10/2011 - 06/2010

Drug/Important Bio-Agent (IBA)

47	Biomarkers (Surrogate Marker)IBA 12/2022 - 10/2006
35	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2002
25	Hormones (Hormone)IBA 01/2022 - 06/2011
13	Estrogens (Estrogen)FDA Link 04/2020 - 01/2013
11	Proteins (Proteins, Gene)FDA Link 04/2021 - 11/2008
10	ORALIT (ORS)IBA 01/2021 - 06/2012
10	AntibodiesIBA 01/2019 - 05/2006
9	Biological ProductsIBA 04/2020 - 01/2013
9	Oral ContraceptivesIBA 01/2020 - 01/2009
8	Messenger RNA (mRNA)IBA 01/2022 - 10/2008
8	Estradiol (Delestrogen)FDA LinkGeneric 04/2020 - 07/2013
7	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2022 - 12/2006
7	Cyclin-Dependent Kinase Inhibitor p16IBA 06/2015 - 10/2006
6	Coloring Agents (Dyes)IBA 01/2023 - 12/2014
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 11/2012
6	VaccinesIBA 01/2022 - 08/2009
6	AntigensIBA 12/2020 - 05/2007
5	mahuang-tangIBA 01/2020 - 08/2012
5	RNA (Ribonucleic Acid)IBA 10/2019 - 10/2008
4	Talc FDA Link 01/2022 - 09/2014
4	Pharmaceutical PreparationsIBA 01/2022 - 11/2012
4	PowdersIBA 10/2021 - 01/2020
4	CytokinesIBA 04/2020 - 01/2014
4	ChemokinesIBA 04/2020 - 01/2014
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2017 - 11/2012
4	Transcription Factors (Transcription Factor)IBA 02/2017 - 02/2014
3	LipidsIBA 01/2021 - 01/2019
3	AdipokinesIBA 04/2020 - 07/2013
3	C-Reactive ProteinIBA 04/2020 - 11/2014
3	Testosterone (Sustanon)FDA Link 10/2019 - 01/2017
3	AndrogensIBA 10/2019 - 01/2017
3	ParaffinIBA 10/2019 - 11/2015
3	Estrone FDA Link 09/2019 - 01/2016
3	Analgesics (Analgesic Drugs)IBA 01/2019 - 02/2014
3	Oncogene Proteins (Oncogene Protein)IBA 01/2019 - 12/2008
3	Insulin-Like PeptidesIBA 05/2017 - 01/2016
3	Estrogen ReceptorsIBA 02/2016 - 04/2013
3	MicroRNAs (MicroRNA)IBA 01/2016 - 06/2011
3	Interleukin-8 (Interleukin 8)IBA 06/2015 - 04/2014
2	tetrahydrozoline (Visine)FDA Link 10/2021 - 07/2021
2	AsbestosIBA 10/2021 - 11/2014
2	Troleandomycin (TAO)FDA Link 10/2021 - 01/2021
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2015
2	Linoleic Acid (Linoleate)IBA 12/2020 - 01/2019
2	Arachidonic Acid (Vitamin F)IBA 12/2020 - 01/2019
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 04/2020 - 02/2017
2	AdiponectinIBA 04/2020 - 07/2013
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2020 - 05/2007
2	GonadotropinsIBA 01/2020 - 03/2015
2	Progestins (Progestagens)IBA 11/2019 - 01/2013
2	Androstenedione (4 Androstene 3,17 dione)IBA 09/2019 - 01/2017
2	Vitamin D FDA LinkGeneric 01/2019 - 10/2016
2	CC ChemokinesIBA 01/2019 - 01/2017
2	Genetic Markers (Genetic Marker)IBA 01/2019 - 03/2016
2	LigandsIBA 01/2019 - 01/2017
2	Insulin (Novolin)FDA Link 01/2019 - 01/2016
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2019 - 02/2014
2	HLA Antigens (Human Leukocyte Antigens)IBA 11/2018 - 01/2017
2	HLA-DRB1 Chains (HLA DRB1)IBA 11/2018 - 01/2017
2	Amino Acids FDA Link 09/2017 - 01/2017
2	Peptides (Polypeptides)IBA 01/2017 - 06/2010
2	InterleukinsIBA 01/2017 - 11/2014
2	HLA-B Antigens (HLA-B)IBA 01/2017 - 01/2017
2	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2016 - 01/2014
2	cyclo(Arg-Pro) (CI 4)IBA 12/2015 - 01/2015
1	SmokeIBA 01/2022

Therapy/Procedure

15	Therapeutics 01/2022 - 01/2013
6	Hysterectomy 10/2022 - 12/2015
6	Tubal Sterilization (Tubal Ligation) 10/2020 - 11/2012
2	Menstrual Hygiene Products (Menstrual Pad) 01/2020 - 04/2015
2	Curettage 12/2017 - 10/2015
2	Drug Therapy (Chemotherapy) 12/2015 - 01/2008
2	Contraception (Birth Control) 09/2015 - 11/2012